Roche Plans To Invest Up To $550M In Its Diagnostics Site In Indianapolis By 2030

0.00%

+2.09%

ROCHE HOLDINGS AG

RHHBF

352.00

0.00%

ROCHE HOLDINGS AG

RHHBY

41.95

+2.09%

An investment of up to $550 million by 2030 will establish the Indianapolis site as a hub for manufacturing of Roche's continuous glucose monitoring solution.
Expansion will create hundreds of jobs while also enhancing U.S. production capabilities.
Increased access to diabetes management tools will help improve health outcomes for patients in the U.S. and globally.

INDIANAPOLIS, May 12, 2025 /PRNewswire/ -- Roche ((SIX: RO, ROG, OTCQX:RHHBY) announced today it plans to invest up to $550 million in its Diagnostics site in Indianapolis by 2030. The site will become a major hub for the manufacturing of Roche's continuous glucose monitoring (CGM) systems – marking a new milestone in Roche's long history of revolutionizing healthcare across the globe.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.